Aurinia Pharmaceuticals Inc. Inventory Write-down
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-02-26
- Aurinia Pharmaceuticals Inc. inventory write-down for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Aurinia Pharmaceuticals Inc. inventory write-down for the quarter ending 2022-12-31 was $1.18M, a 382.45% increase year-over-year.
- Aurinia Pharmaceuticals Inc. inventory write-down for the quarter ending 2021-12-31 was $245.00K.
- Aurinia Pharmaceuticals Inc. inventory write-down for fiscal 2025 was $0.00.
- Aurinia Pharmaceuticals Inc. inventory write-down for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Aurinia Pharmaceuticals Inc. inventory write-down for fiscal 2023 was $916.00K, a 74.88% decline from fiscal 2022.
- Aurinia Pharmaceuticals Inc. inventory write-down for fiscal 2022 was $3.65M, a 1388.16% increase from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $916.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $916.00K 10-Q · filed 2023-11-02 | ||
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.65M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $2.46M 10-Q · filed 2023-11-02 | ||
| 2021-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $245.00K 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |